United Therapeutics Corporation Convertible Notes Payable, Noncurrent
United Therapeutics Corporation (UTHR) had Convertible Notes Payable, Noncurrent of $207.38 million as of 2013-03-31, per its 10-Q filed 2013-04-25.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Notes Payable, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2014-02-25
- 2013-03-31: Convertible Notes Payable, Noncurrent $207.38M.
- 2012-12-31: Convertible Notes Payable, Noncurrent $204.67M.
- 2012-09-30: Convertible Notes Payable, Noncurrent $201.97M.
- 2012-06-30: Convertible Notes Payable, Noncurrent $199.34M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2013-03-31 | $207.38M 10-Q · filed 2013-04-25 |
| 2012-12-31 | $204.67M 10-K · filed 2014-02-25 |
| 2012-09-30 | $201.97M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $199.34M 10-Q · filed 2012-07-26 |
| 2012-03-31 | $196.73M 10-Q · filed 2012-04-26 |
| 2011-12-31 | $194.18M 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |